Descripción del proyecto
Acelerar la investigación, innovación y aplicación de la medicina personalizada
En el cambiante panorama de la asistencia sanitaria, la integración de enfoques de medicina personalizada (MP) en sistemas sanitarios sostenibles constituye una oportunidad para los ciudadanos y la sociedad. Sin embargo, varias lagunas siguen obstaculizando el desarrollo y la aplicación de la MP. En este contexto, el proyecto EP PerMed, financiado con fondos europeos, tiene por objeto promover la investigación y la innovación en el ámbito de la MP y acelerar su integración en los sistemas sanitarios. La iniciativa aborda la necesidad básica de fomentar la colaboración y traducir las innovaciones de la MP en beneficios para las personas y la sociedad. En EP PerMed se hace hincapié en la participación de los pacientes, la colaboración a lo largo del «continuo de valor» (integrando investigación, innovación y aplicación) y el compromiso internacional. De este modo, se contribuirá a respaldar carteras de proyectos y se posibilitará la transformación de sus logros en innovaciones sanitarias de éxito.
Objetivo
EP PerMed is a new European Partnership dedicated to Personalised Medicine (PM). It supports PM-related R&I, but also facilitates and accelerates all steps so that PM achievements successfully pass through the full value continuum to be implemented in sustainable health systems for the benefit of people and societies. The partnership will foster demonstration projects and promote successes and lessons learned to demonstrate evidence of PM implementation. EP PerMed activities cover overarching aspects, like patient involvement, exchange with medical societies, infrastructures and international and regional collaboration. The project portfolios of EP PerMed and ERA PerMed (ERA-Net co-fund on PM) and others are supported to become successful innovations in healthcare practice. EP PerMed will be the global PM-platform for scientific and strategic dialogue and alignment, resulting in public documents and publications. Accordingly, it will inform the public, patients, healthcare providers or payers about the latest PM options and engage them.
The Strategic Research and Innovation Agenda for Personalised Medicine (SRIA for PM, 2023), developed by EP PerMed partners, is the basis for the partnership's structure and a wide range of its activities. All steps of the SRIA development were strongly support by numerous PM-experts, stakeholders and the European Commission (EC). Thus, the EP PerMed annual Joint Transnational Calls (JTCs) and other funding and activities, events and tools will be in line with the SRIA and outputs will feed into a SRIA update in the coming years.
The partnership builds on several developments, initiatives and projects such as ERA PerMed, ICPerMed and its supporting projects (“ICPerMed Family”) funded by the EC. In parallel, it reaches out to the 1+Million Genomes Initiative, other European Partnerships in the Health Cluster and infrastructures like the European Strategy Forum on Research Infrastructures (ESFRI).